Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.27
-5.22 %
$ 205 M
Market Cap
127.0
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ironwood Pharmaceuticals, Inc.
| Net Income | 880 K |
| Depreciation & Amortization | 2.01 M |
| Capital Expenditures | -142 K |
| Stock-Based Compensation | 29.8 M |
| Change in Working Capital | 739 K |
| Others | -24.3 M |
| Free Cash Flow | 103 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||||
| Net Income | 0.9 | (1 002.2) | 175.1 | 528.4 | 106.2 | 21.5 | (282.4) | (116.9) | (81.7) | (142.7) | (189.6) | (272.8) | (72.6) | (64.9) | (56.4) | (73.3) | (55.0) | (53.2) | (37.2) |
| Depreciation & Amortization | 2.0 | 1.6 | 1.4 | 1.5 | 3.6 | 5.6 | 14.2 | 14.6 | 11.3 | 11.6 | 12.3 | 11.7 | 11.3 | 10.0 | 6.2 | 5.2 | 2.8 | 1.7 | 1.3 |
| Deferred Income Tax | 68.1 | 72.6 | 65.7 | (333.3) | 6.6 | 35.9 | 159.1 | 7.5 | (7.3) | 28.5 | 21.5 | 1.9 | 0 | 7 K | (5.5) | 1.0 | 1 K | 1 K | 0 |
| Stock Based Compensation | 29.9 | 32.0 | 27.0 | 22.3 | 31.2 | 31.3 | 44.0 | 33.8 | 29.2 | 25.5 | 26.2 | 19.8 | 17.6 | 11.7 | 7.5 | 5.2 | 2.8 | 1.2 | 0 |
| Other Operating Activities | 2.0 | 1 068.2 | 1.7 | 25.2 | 22.3 | 16.4 | (13.4) | (16.8) | 28.1 | 8.4 | 4.1 | 1.7 | 1.2 | 2.2 | 1.6 | (0.4) | 0.5 | (1.7) | 0.2 |
| Change in Working Capital | 0.7 | 11.3 | 2.8 | 17.7 | (0.9) | (100.0) | 7.6 | (21.8) | (5.0) | (38.2) | (30.1) | (35.7) | (27.1) | (34.4) | (21.3) | 58.2 | 20.7 | 45.2 | 2.1 |
| Cash From Operations | 103.5 | 183.4 | 273.8 | 261.9 | 168.8 | 10.7 | (70.9) | (99.6) | (25.4) | (106.9) | (155.6) | (273.4) | (69.6) | (75.2) | (67.9) | (4.0) | (28.2) | (6.8) | (33.5) |
| INVESTING CASH FLOW | |||||||||||||||||||
| Capital Expenditures | (0.1) | (0.3) | (0.1) | (0.3) | (1.8) | (7.2) | (8.6) | (4.2) | (104.2) | (4.0) | (3.5) | (9.6) | (14.0) | (9.7) | (17.2) | (4.0) | (22.9) | (2.7) | (2.8) |
| Other Items | 0 | (1 026.0) | 0 | 0 | 0 | (4.0) | 97.5 | 155.7 | (73.5) | (5.1) | (53.0) | (91.8) | 44.1 | 124.7 | (195.8) | 21.8 | 7.9 | (25.0) | (2.8) |
| Cash From Investing Activities | (0.1) | (1 026.3) | (0.1) | (0.3) | (1.8) | (11.1) | 88.9 | 151.5 | (177.7) | (9.2) | (56.6) | (101.4) | 30.1 | 115.1 | (213.0) | 17.8 | (15.1) | (27.6) | (5.6) |
| FINANCING CASH FLOW | |||||||||||||||||||
| Common Stock Repurchased | 0 | 0 | (126.4) | (24.1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (115.0) | 300.0 | (120.7) | 0 | 0 | 7.2 | (1.8) | 8.8 | (28.8) | 321.7 | (2.2) | 174.2 | (0.3) | (0.3) | (2.0) | 1.1 | (1.2) | 0.7 | (1.9) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 8.0 | (22.8) | 9.5 | 19.6 | 18.5 | (8.4) | 31.9 | 11.1 | 24.6 | (18.6) | 22.7 | 1.6 | 4.0 | 3.4 | 1.7 | 40.5 | 49.8 | 50.0 | 7.0 |
| Cash From Financing Activities | (107.0) | 277.2 | (237.6) | (4.5) | 18.5 | (1.2) | 30.1 | 19.8 | (4.2) | 303.1 | 210.9 | 313.6 | 89.0 | 3.1 | 203.0 | 41.7 | 48.6 | 50.7 | 80.1 |
| CHANGE IN CASH | |||||||||||||||||||
| Net Change In Cash | (3.6) | (565.8) | 36.1 | 257.1 | 185.5 | (1.6) | 48.1 | 71.7 | (207.3) | 187.0 | (1.2) | (61.2) | 49.4 | 43.0 | (78.0) | 55.4 | 5.3 | 16.4 | 0 |
| FREE CASH FLOW | |||||||||||||||||||
| Free Cash Flow | 103.4 | 183.2 | 273.6 | 261.6 | 167.0 | 3.5 | (79.5) | (103.8) | (129.6) | (111.0) | (159.1) | (282.9) | (83.6) | (84.9) | (85.1) | (8.0) | (51.1) | (9.4) | (36.4) |